| Incyte Corp | 70.8500 / +0.77% |
| Date/Time | 03/29 / 17:19 |
| Chg. / Chg.(%) | 0.5400 / +0.77% |
| Bid | 70.8300 / 200 |
| Ask | 70.8600 / 1100 |
| Open | 70.7300 |
| Previous Close | 70.3100 |
| High | 71.1000 |
| Low | 70.5100 |
| Volume [USD] | 9,025,698.6653 |
| Volume [Units] | 199,125 |
| Price fixings | 848 |
| ISIN | US45337C1027 |
| Security | INCY |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 70.8500 |  |
199,125 |
| IEX | 70.90 | |
16,551 |
| Cboe US | 71.03 |  |
6,919 |
| Frankfurt | 64.9100 | |
200 |
| Hannover | 65.15 | |
0 |
| München | 65.49 | |
0 |
| Düsseldorf | 65.23 | |
0 |
| Berlin | 65.44 | |
0 |
| Lang & Schwa.. | 65.36 | |
|
| Stuttgart | 64.960 | |
|
| Quotrix | 65.2300 | |
|
| gettex | 65.420 | |
|
| TradeGate | 65.690 | 93 | |
| London Domes.. | 72.26 | 3,019 |
News
- Wall Street back to losses, Dow slides 200 points
02/07/2023 / 19:53 - TeleTrader - US markets lower amid economic data, Fed's Powell
02/07/2023 / 15:30 - TeleTrader - RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire
Real-time